Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Processa Pharmaceuticals, Inc.

NASDAQ: PCSA · Life Sciences · 5 alerts · CIK 1533743

Share price
$1.72Close, Nov 16
Market cap
$4.81M
Shares outstanding
2.8MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Processa Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:21 AM ET 8-K/A
M&A Deal

Processa Pharmaceuticals M&A Deal with Vidya Therapeutics, Inc.

Processa Pharmaceuticals filed an amendment to its 8-K to provide audited financial statements and pro forma information following its acquisition of Vidya Therapeutics. The deal adds VT7208, a CNS-penetrant BTK inhibitor, to Processa's pipeline for the treatment of autoimmune conditions like multiple sclerosis and food allergies.

Counterparty
Vidya Therapeutics, Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.